Filana Therapeutics, Inc. (FLNA)
NASDAQ · Manufacturing · Pharmaceutical preparations
FLNA price, last 12 months
Key stats
- Previous close
- $0.5450
- Open
- $0.5800
- Day range
- $0.5252 – $0.6156
- 52-week range
- $0.3900 – $2.27
- Volume
- 781.7K
- Avg volume (20 days)
- 509K
- Market cap
- $21.4M
Performance
Technicals and fundamentals
About Filana Therapeutics, Inc.
Filana Therapeutics Inc is a biotechnology company focused on developing novel, investigational therapies to modulate the filamin A protein for the treatment of central nervous system disorders, such as tuberous sclerosis complex (TSC)-related epilepsy, and other diseases associated with dysregulation or overexpression of filamin A. Its therapeutic product candidate, simufilam, is a proprietary small molecule oral treatment drug being studied for the treatment of TSC-related epilepsy.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $21.4M